BIOMARIN PHARMACEUTICAL INC (BMRN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for BMRN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BMRN | Director, Enovis Corp. | 58 | ["Director, Option Care Health, Inc.","extensive experience serving on the boards of biotechnology and pharmaceutical organizations","financial and accounting expertise","interim Chief Financial Officer of Dentsply Sirona Inc.","Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, Inc.","Senior Vice President of Finance of Mallinckrodt Pharmaceuticals","senior finance roles at Hospira, Inc. and Eli Lilly and Company","holds a B.S. in Finance","M.B.A from Indiana University"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| OPCH | Independent Director | 58 | ["Interim Chief Financial Officer of DENTSPLY Sirona Inc.","Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, Inc.","Senior Vice President, Finance, of Mallinckrodt plc","Vice President, Global Commercial Finance of Hospira","Positions of increasing responsibility at Eli Lilly & Company","Extensive finance, accounting, and risk management experience","Significant healthcare industry experience","Experience with corporate governance matters, risk management, and management oversight"] | ["Audit and Finance Committee","Compensation Committee","Audit and Finance","Nominating and Corporate Governance"] | 2026 |
| ENOV | Former Chief Financial Officer; Director | 58 | ["Former Chief Financial Officer, Hill-Rom Holdings, Inc.","Extensive finance, accounting and risk management experience, including as a public company chief financial officer","Significant medical device and healthcare industry experience","Board leadership experience as an audit committee member and chair, nom/gov committee member and compensation committee member"] | ["Audit"] | 2026 |